If thereâ€™s a field over the last 100 years that technology and innovation have been instrumental in propelling forward, itâ€™s health care. Since 1934,Â mortality rates have dropped roughly 60%Â thanks to the benefits of progress in medicine.
Wednesday morning, the U.S. Chamber of Commerce hosted â€œSolving The Drug-Pricing Challenge: Policy Reforms To Expand Drug Access, Accelerate Innovation, And Grow The Economy,â€� an event focused on affordable access to prescription drugs while also encouraging innovation in the medical industry. Former Oklahoma Senator Tom Coburn, MD gave the keynote address and a panel discussion of distinguished writers and scholars followed afterward.
Dr. Coburn touched on several issues affecting American healthcare in the 21stÂ century, namely the role of government in health care,Â theÂ efficient use of resources, andÂ policies toÂ encourageÂ technological innovation.
The former Senator stressed that theÂ federal government is not always the solution:Â
â€œCongress is not going to solve ourÂ health care dilemma,Â [but rather] markets will solve ourÂ health care dilemma.â€�
For Coburn, the American economy is an â€œunbeatableâ€� force and it is what will propel the United States to the forefront of medicine. Not only does Coburn suggest that the United States should â€œrestoreÂ personal accountability in health care,â€� but alsoÂ â€œreward efficiencyâ€� and best practices. He asserted that if American resources are used efficiently, then the U.S. will remain ahead.
In addition to better use of American resources and services, Coburn expressed concern with protection of intellectual property (IP) and the continuation of innovation in medicine. He argued that investing in technology jobs should be a top priority for the industry. Coburn credits the innovations of Silicon Valley for not only creating biotech jobs, but also putting the U.S. at the cutting edge of innovation.
He does have a point. According to theÂ U.S. Chamber of Commerceâ€™s International Intellectual Property (IP) Index, economies with more robust IP protection hold a number of advantages over their weaker counterparts. They are more likely to contribute to biotech innovation, have 15 times more investment in the life sciences, andÂ have access toÂ more clinical trials on new drugs.
With encouraged innovation, Coburn believes that we will solve this dilemma. But this issue is not solely based on price. It also hinges on giving Americans access to resources that allow doctors, researchers, and scientists to find cures and move medicine forward.
Near the end of his speech, Coburn remarked, â€œWe want to lead the worldâ€� in regard to medicine. With investment in research and development and efficient use of resources, Coburnâ€™s dream can certainly become a reality. It depends on if weâ€™re willing to foster a new generation of cures by investing heavily in innovation, competition, and technology.
more recommended stories
- Special Weather Statement issued August 23 at 2:11AM EDT by NWS
…A developing strong thunderstorm in northern.
- University loses students, major donations after they reinstate racist anti-white professor
(AP Photo/Dave Collins) Johnny Eric.
- Rights defenders â€˜must not be silenced,â€™ says UN office, urging Turkey to release activists
7 July 2017 â€“ The United.
- North Korea Claims It Tested First Intercontinental Missile
This image made from video of.
- Getting Creative with Instagram
By Lisa Jane on Tuesday.
- A small sign in a big state shows the future is libertarian
(AP Photo) High schoolers all across.
- One in 10 LinkedIn Profiles is a Complete Lie, Study Finds – Takeaway for Small Business Employers
Looking to fill a job vacancy.
- An alternative to college: Ivanka unveils plans for ‘vocational, skill-based education’
(AP Photo/Evan Vucci) On Monday, Ivanka.
- 10 Things To Know For Today,,,
President Donald Trump, first lady Melania.
- Full Steam Ahead? The Chelsea Train Is Back
(Photo via ABC) In this political.